AMOT and ovarian carcinoma: However, in some cancers, including renal, hepatic and ovarian cancer, there is also evidence for a YAP-activating role of AMOT in the nucleus [103,104], and a recent study identified the involvement of an AMOT-binding long noncoding RNA in this nuclear activity [105].